Evecxia Therapeutics

Raleigh, United States

Evecxia Therapeutics is a pharmaceutical company that develops drugs to help patients suffering from disabling neuropsychiatric conditions.

$5.0M raised

Sep 2025

Series A

Health Care Pharmaceutical Therapeutics

Top Investors

Daren Cotter Viva BioInnovator

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Evecxia Therapeutics

How much funding has Evecxia Therapeutics raised?

Evecxia Therapeutics has raised $5.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.

Who are Evecxia Therapeutics's investors?

Evecxia Therapeutics's investors include Daren Cotter, Viva BioInnovator.

Where is Evecxia Therapeutics headquartered?

Evecxia Therapeutics is headquartered in Raleigh, United States.

What does Evecxia Therapeutics do?

Evecxia Therapeutics is a pharmaceutical company that develops drugs to help patients suffering from disabling neuropsychiatric conditions.

What stage is Evecxia Therapeutics at?

Evecxia Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 22, 2025.

MLA

"Evecxia Therapeutics — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/evecxia-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Evecxia Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/evecxia-therapeutics

Wikipedia (cite web)

{{cite web |title=Evecxia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/evecxia-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 22, 2025.